Industry news

• The Government has approved an action plan to combat hepatitis C

  09 November 2022 GxPnews

  Russia is planning to develop a system of medical care to patients with hepatitis C and improve the mechanisms for funding such treatment on the basis of compulsory medical insurance (CHI). This is provided for in the action plan to combat the disease. The document was approved by Government Decree No. 3306-r dated November 2, 2022.

• Alternative immunotherapies improve relapsed myeloma survival

  08 November 2022 Catherine Eckford / European Pharmaceutical Review

  Researchers from Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) have found that bispecific antibodies (BsAbs), stem cell transplants and other CAR-T (chimeric antigen receptor T-cell) therapies offered relapsed multiple myeloma (RRMM) patients 18 months median overall survival (OS) after failed B-cell Maturation Antigen (BCMA) CAR-T therapy.

• First patients given lab-grown blood cell transfusion

  08 November 2022 Catherine Eckford / European Pharmaceutical Review

  The second-ever patient has been transfused with lab-grown red blood cells in a clinical trial, promising an effective treatment for patients.

• Solving the taxing problems of taxanes?

  07 November 2022 Colin Freund / European Pharmaceutical Review

  Could the new wave of taxane chemotherapies succeed where traditional chemotherapies have failed? Colin Freund, Chief Executive Officer of Modra Pharmaceuticals, reveals the benefits of this emerging generation of anticancer treatment.

• Clinical success begins early for small molecule drugs

  07 November 2022 Abhijeet Sinha / European Pharmaceutical Review

  First-in-human clinical verification is one of the first critical milestones in drug development. Abhijeet Sinha, Senior Scientist at Lonza Small Molecules, exemplifies the imperative of solving drug development challenges in the early phases.

• Russia and Iran have signed a memorandum of cooperation related to medical products circulation

  03 November 2022 GxPnews

  On November 1, a meeting of the intergovernmental commission on economic cooperation between the Russian Federation and the Islamic Republic of Iran was held in Grozny, chaired by Aleksandr Novak, Deputy Prime Minister, with the support of Ramzan Kadyrov, the Head of the Chechen Republic.

• More than 5,000 people were immunized against COVID-19 with a nasal vaccine in the Moscow region

  02 November 2022 GxPnews

  The Moscow region has vaccinated more than 5,000 people against coronavirus infection with a nasal vaccine. In total, the region has purchased almost 600,000 special nozzles for this vaccination method. This is reported by TASS with reference to Svetlana Strigunkova, the first deputy chairman of the government of the Moscow region.

• The volume of shipments from pharmaceutical companies of St. Petersburg SEZ increased by 16%

  02 November 2022 GxPnews

  According to Dmitry Vakhrukov, Deputy Minister of Economic Development of Russia, residents of St. Petersburg Special Economic Zone (SEZ) are making increasing efforts at providing import substitution in the pharma industry.

• Inaccuracies in the requirements for anti-terrorist passports result in losses for pharmacies

  01 November 2022 GxPnews

  Due to the judicial practice on the issue of anti-terrorist passports, pharmacy organizations are suffering losses. This is reported by FV with reference to the Soyuzfarma association.

• Over 200 million packages of medicines have been bought by Russians on marketplaces over two years

  31 October 2022 GxPnews

  Since the beginning of online sales of over-the-counter medicines, Russians have bought more than 200 million packages on marketplaces. This is reported by TASS with reference to the Center for the Development of Advanced Technologies (TsRPT, the labeling operator).